Medication withdrawal can dramatically alter behavior in people with dementia, sometimes triggering agitation, confusion, aggression, or emotional withdrawal that families misinterpret as disease progression. When a medication is stopped—whether due to medical review, cost, side effects, or hospitalization—the brain’s chemistry shifts suddenly. In dementia patients who already have compromised neurological function, this shift can manifest as behavioral changes within hours to days. A 78-year-old man with mild cognitive impairment whose anxiety medication was discontinued during a hospital stay became so agitated that staff considered antipsychotic sedation, only to stabilize once the medication was restarted.
The relationship between medication withdrawal and behavior is not simply the opposite of starting a medication. Withdrawal effects can be more severe than baseline symptoms because the brain has adapted to the drug’s presence over weeks or months. Stopping certain medications abruptly—particularly benzodiazepines, SSRIs, or cognitive enhancers like donepezil—can trigger rebound effects where the original symptom returns intensified, or entirely new behavioral symptoms emerge. Understanding these risks is critical for dementia caregivers and healthcare providers, because misattributing medication withdrawal to advancing disease can lead to unnecessary new prescriptions that compound the problem.
Table of Contents
- Why Does Stopping Medication Cause Behavioral Changes in Dementia?
- Distinguishing Withdrawal Behavior From Disease Progression
- Which Dementia Medications Carry the Highest Withdrawal Risk?
- How to Safely Reduce or Stop Medications Without Triggering Withdrawal Behavior
- Medication Withdrawal Can Mimic Delirium and Other Acute Conditions
- Medication Withdrawal in Hospitalization and Transition Settings
- Monitoring for Early Signs of Withdrawal and When to Contact the Doctor
Why Does Stopping Medication Cause Behavioral Changes in Dementia?
Medications used in dementia care target specific neurotransmitter systems in the brain. Antidepressants increase serotonin availability; anti-anxiety drugs enhance GABA signaling; cognitive enhancers preserve acetylcholine. When these drugs are present daily for months or years, the brain adjusts its own neurotransmitter production—often reducing it because the external supply is reliable. When the medication stops, the brain’s reduced natural production cannot immediately compensate. This gap between the drug being present and the brain’s own chemistry catching up is the window where behavioral symptoms emerge most acutely. Different drug classes create different withdrawal patterns. Stopping a benzodiazepine like lorazepam in a person with dementia can trigger not only rebound anxiety but also tremors, confusion, or aggressive outbursts within 24 to 72 hours.
Stopping an SSRI antidepressant may cause emotional lability—sudden crying or rage—even in people who showed stable mood while medicated. Stopping donepezil (an Alzheimer’s medication) sometimes results in a noticeable cognitive dip and increased restlessness. A 72-year-old woman with dementia who had her citalopram (an SSRI) halted due to a medication review became emotionally volatile and angry—behaviors her family had not seen in two years—and it took three weeks for her baseline to stabilize again. The severity of behavioral change during withdrawal depends on how long the person has been on the medication, the dose, the specific drug, and the dementia stage. Someone in late-stage dementia with limited verbal ability may not complain of withdrawal symptoms but instead express them through increased agitation, refusing care, or sleeping abnormally. Early-stage dementia patients may directly report anxiety, dizziness, or emotional instability. Healthcare providers sometimes miss medication withdrawal as the cause because they assume behavioral changes only mean advancing cognitive decline.
Distinguishing Withdrawal Behavior From Disease Progression
A critical clinical challenge is that medication withdrawal symptoms and dementia progression can appear identical: increased confusion, restlessness, memory problems, mood changes. The key differentiator is the timeline. Dementia typically progresses gradually over weeks to months; withdrawal effects usually manifest within hours to days after a medication is stopped. If a dementia patient’s behavior shifts sharply after a medication change, withdrawal is a strong possibility. If the change is subtle and gradual over a month, progressive disease is more likely. However, this distinction is not foolproof, and some withdrawal effects develop slowly. A person on multiple medications who stops one drug may not show symptoms for a week, and caregivers or staff may not connect the timing to the medication change.
Hospitalization is a particularly high-risk setting because medications are often held, deprescribed, or changed without clear documentation of why or for how long. One study of hospitalized dementia patients found that unplanned medication discontinuations were linked to increased behavioral incidents, falls, and readmissions—but the root cause was frequently misattributed to infection, delirium, or worsening cognitive status rather than withdrawal. This misattribution often leads to adding new medications (like antipsychotics) that were not necessary, creating a cascade of side effects. Complicating matters further, some medication withdrawals cause behavioral changes while others do not. Stopping a statin or blood pressure medication typically has no acute behavioral effect. Stopping a psychiatric, neurological, or pain medication is more likely to cause behavioral symptoms. A limitation of withdrawal diagnosis is that there is no biological test for it—diagnosis relies on clinical observation and timeline correlation, which means some cases go unrecognized and untreated.
Which Dementia Medications Carry the Highest Withdrawal Risk?
Cognitive-enhancing medications like donepezil, rivastigmine, and galantamine are some of the most commonly used drugs in dementia care, yet many families and even some providers do not realize they have withdrawal effects. Stopping these medications abruptly can result in cognitive decline, increased confusion, and behavioral agitation within days. A 74-year-old man with moderate Alzheimer’s whose donepezil was stopped due to gastric side effects showed marked confusion and restlessness within 48 hours; his family reported he seemed “worse” than before starting the medication. When the donepezil was restarted at a lower dose, his behavior and cognition improved again. Psychiatric medications carry equally significant withdrawal risks. Benzodiazepines (lorazepam, diazepam) are sometimes prescribed for anxiety or agitation in dementia, and they are among the most difficult medications to withdraw safely; stopping them abruptly can trigger seizures, severe anxiety, or dangerous behavioral changes.
SSRIs (sertraline, citalopram, escitalopram) used for depression or anxiety can cause discontinuation syndrome—a cluster of symptoms including emotional instability, dizziness, and agitation—if stopped suddenly. Antipsychotics used for behavioral control carry their own withdrawal risks; stopping them may result in rebound agitation or psychotic symptoms in some patients. The challenge is that these medications are sometimes stopped specifically because of concerns about their side effects or appropriateness in older adults, which makes the withdrawal effects feel like a cruel trade-off. Pain medications also pose withdrawal risks, particularly opioids and certain antiepileptic drugs used off-label for pain. Abrupt discontinuation can intensify pain perception and cause anxiety or agitation. The safest approach for any psychiatric, neurological, or pain medication is a slow taper—reducing the dose gradually over weeks or months—rather than cold-turkey cessation, but this requires planning and coordination between the person’s doctor, pharmacy, and caregivers.
How to Safely Reduce or Stop Medications Without Triggering Withdrawal Behavior
The gold standard for discontinuing medications in dementia patients is a gradual taper: reducing the dose slowly over a period of weeks to months, depending on the drug and duration of use. This allows the brain’s own neurotransmitter production to ramp up without creating a neurochemical cliff. For a person who has been on a benzodiazepine for years, the taper might last two to three months; for an SSRI, four to eight weeks is typical. During the taper, behavior should be monitored closely for withdrawal symptoms, and the pace of reduction can be slowed if symptoms emerge. The tradeoff of a slow taper is that it requires coordination, patience, and adherence. It is easier for a busy practice to stop a medication abruptly, and it is tempting for families to think a quick cessation is safer if they are concerned about side effects.
However, rushing the process almost always backfires: withdrawal symptoms appear, families assume the medication was harmful, and a new medication is added to manage the withdrawal symptoms—resulting in a patient on more drugs, with more side effects, and no clear benefit. A documented example is a woman with early dementia whose family requested immediate discontinuation of her low-dose antipsychotic due to fall risk; within three days of stopping, she became hallucinating and agitated; an antidepressant and an anti-anxiety medication were added to manage these withdrawal symptoms, and she ended up on a more complex regimen than before. Before stopping or reducing any medication, the prescribing doctor should be consulted to establish a taper schedule. If the person is in a facility or hospital, the care team should be informed of the plan and asked to document behavior during the taper. Caregivers should keep a simple log: date, dose change, and any behavioral or physical changes observed. This record helps the doctor adjust the taper speed if withdrawal symptoms appear.
Medication Withdrawal Can Mimic Delirium and Other Acute Conditions
One of the most dangerous aspects of medication withdrawal in dementia is that its symptoms overlap almost completely with delirium—an acute state of confusion, disorientation, and behavioral disturbance. Family members and medical staff often respond to withdrawal-induced behavioral changes by ordering tests: blood cultures to rule out infection, urinalysis to check for UTI, imaging to check for stroke. These tests are not unreasonable, but they sometimes distract from the simpler explanation: a medication was recently stopped or changed. The challenge is that delirium and infection are real risks in dementia patients, so every acute behavioral change cannot be assumed to be medication withdrawal. However, the temporal relationship is informative.
If a patient became acutely confused immediately after a medication change, medication withdrawal or a direct effect of a new medication is a plausible cause. If the person was stable for a week on the new regimen and then suddenly deteriorated, infection or another medical event is more likely. A limitation in clinical practice is that electronic medical records often do not flag recent medication discontinuations prominently, so the connection is missed unless a provider manually reviews the medication history and timestamps of behavioral change. In some cases, medication withdrawal and infection or other illness co-occur. A person hospitalized for pneumonia may have antibiotics started and a psychiatric medication discontinued simultaneously; the behavioral deterioration that follows might be partly withdrawal and partly delirium from infection. This mixed presentation makes diagnosis harder and underscores the importance of communication between the hospital and family: the family can often clarify whether the behavioral change mirrors previous withdrawal episodes (in which case medication resumption might help) or seems like a new illness (in which case diagnostic workup is appropriate).
Medication Withdrawal in Hospitalization and Transition Settings
Hospitals are a particularly high-risk environment for unintended medication withdrawal in dementia patients. Many medications are held during hospitalization as a precaution—a practice called “deprescribing” that is well-intentioned when the goal is to reduce polypharmacy but can backfire if the patient’s psychiatric or neurological medication is included. Additionally, hospital formularies sometimes do not stock the exact medication the patient was taking at home, and substitutions are made without clear communication; if a substitute is less effective or is not continued, withdrawal or functional decline can result. A specific example: a man with mild dementia on a stable regimen of donepezil, sertraline, and lorazepam for anxiety was hospitalized for hip surgery. Hospital policy held all non-essential medications during admission; his psychiatric medications were placed on hold.
Post-operatively, he became extremely agitated and confused, which was attributed to post-operative delirium. His psychiatric medications were not resumed for two days, during which he pulled out his catheter and required restraint. When his medications were finally restarted, his behavior normalized rapidly. The “delirium” was largely medication withdrawal and the stress of hospitalization, not a complication of the surgery itself. Transitional care facilities (skilled nursing homes, rehabilitation centers) are similarly vulnerable. An older person discharged from hospital may arrive with a list of medications on hold or recently discontinued, and if the facility does not clarify with the discharging hospital or primary care doctor whether those medications should be resumed, the patient remains off them—and withdrawal symptoms can persist or worsen during the transition period.
Monitoring for Early Signs of Withdrawal and When to Contact the Doctor
Caregivers are often the first to notice behavioral changes because they spend the most time with the dementia patient. Early signs of medication withdrawal are worth reporting to the doctor even if they seem minor: increased irritability, tearfulness, sleep disruption, new restlessness, or resistance to care that was previously accepted. These subtle changes often precede more obvious behavioral crises, and early intervention—whether by resuming the medication or adjusting the taper schedule—can prevent escalation.
A person stopping a benzodiazepine should be watched for tremor, rapid heartbeat, or severe anxiety; a person stopping an SSRI should be monitored for emotional instability or agitation; a person stopping a cognitive enhancer should be assessed for increased confusion or restlessness. If these symptoms appear, the doctor should be contacted the same day if possible, or within 24 hours. Waiting to see if symptoms resolve on their own is generally not advisable, because withdrawal symptoms tend to worsen without intervention, and the longer they persist, the more behavioral damage they can do—including increased falls, self-injury, or aggression toward caregivers. In some cases, temporarily resuming the medication or slowing the taper can resolve the crisis and allow a safer, more gradual withdrawal plan to be developed.
